Dexamethasone inhibits activation of monocytes/macrophages in a milieu rich in 27-oxygenated cholesterol

Molecular mechanisms underlying the decreased number of macrophages and T cells in the arteries of cholesterol-fed-rabbits following dexamethasone administration are unknown. We investigated the possibility that dexamethasone could affect activation of monocytic cells induced by oxygenated derivatives of cholesterol (oxysterols) using THP-1 monocyte/macrophage cells. 27-Hydroxycholesterol (27OHChol), an oxysterol elevated with hypercholesterolemia, enhanced production of CCL2, known as MCP1, chemokine from monocytes/macrophages and migration of the monocytic cells, but the CCL2 production and the cell migration were reduced by treatment with dexamethasone. Dexamethasone inhibited superproduction of CCL2 induced by 27OHChol plus LPS and attenuated transcription of matrix metalloproteinase 9 as well as secretion of its active gene product induced by 27OHChol. The drug downregulated cellular and surface levels of CD14 and blocked release of soluble CD14 without altering transcription of the gene. Dexamethasone also inhibited expression and phosphorylation of the NF-κB p65 subunit enhanced by 27OHChol. Collectively, these results indicate that dexamethasone inhibits activation of monocytes/macrophages in response to 27OHChol, thereby leading to decreased migration of inflammatory cells in milieu rich in oxygenated derivatives of cholesterol.

[1]  Emma L. Smith,et al.  The Regulation of NF-κB Subunits by Phosphorylation , 2016, Cells.

[2]  Koanhoi Kim,et al.  27-Hydroxycholesterol up-regulates CD14 and predisposes monocytic cells to superproduction of CCL2 in response to lipopolysaccharide. , 2015, Biochimica et biophysica acta.

[3]  Koanhoi Kim,et al.  FSL-1, a Toll-like Receptor 2/6 Agonist, Induces Expression of Interleukin-1α in the Presence of 27-hydroxycholesterol , 2014, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[4]  C. Mineo,et al.  The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. , 2014, Cell metabolism.

[5]  Y. Yun,et al.  27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes. , 2014, Toxicology and applied pharmacology.

[6]  Koanhoi Kim,et al.  27-Hydroxycholesterol induces recruitment of monocytic cells by enhancing CCL2 production. , 2013, Biochemical and biophysical research communications.

[7]  R. Khokha,et al.  Metalloproteinases and their natural inhibitors in inflammation and immunity , 2013, Nature Reviews Immunology.

[8]  P. Mark,et al.  Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-κB. , 2012, Molecular human reproduction.

[9]  L. Corcos,et al.  7β-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells , 2009, Cell Biology and Toxicology.

[10]  J. Brewer,et al.  Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. , 2007, Blood.

[11]  C. Förster,et al.  Dexamethasone induces the expression of metalloproteinase inhibitor TIMP‐1 in the murine cerebral vascular endothelial cell line cEND , 2007, The Journal of physiology.

[12]  J. Whitsett,et al.  Surfactant Protein-D Regulates Soluble CD14 through Matrix Metalloproteinase-121 , 2005, The Journal of Immunology.

[13]  L. Corcos,et al.  Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols , 2005, Cell Biology and Toxicology.

[14]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[15]  A. Luttun,et al.  Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.

[16]  Khusru Asadullah,et al.  Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.

[17]  D. Scott‐Algara,et al.  Implication of natural killer T cells in atherosclerosis development during a LPS‐induced chronic inflammation , 2002, FEBS letters.

[18]  E. L. Batista,et al.  Porphyromonas gingivalis Infection Accelerates the Progression of Atherosclerosis in a Heterozygous Apolipoprotein E–Deficient Murine Model , 2002, Circulation.

[19]  J. Fallon,et al.  Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits. , 2001, Atherosclerosis.

[20]  P. Armstrong,et al.  Adverse effects of corticosteroids on the cardiovascular system. , 2000, The Canadian journal of cardiology.

[21]  Andrew J. Brown,et al.  Oxysterols and atherosclerosis. , 1999, Atherosclerosis.

[22]  S. Monier,et al.  Different patterns of IL‐1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α‐, 7β‐hydroxycholesterol, or 7‐ketocholesterol , 1998 .

[23]  C. Ford,et al.  Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis , 1996, Neurology.

[24]  M. C. Hu,et al.  Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. , 1996, Journal of immunology.

[25]  C. van der Veen,et al.  Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. , 1995, Biochimica et biophysica acta.

[26]  F. Blecha,et al.  CD14 and other recognition molecules for lipopolysaccharide: a review. , 1995, Immunopharmacology.

[27]  J. Guyton,et al.  Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  R. Ulevitch,et al.  The CD14 differentiation antigen mediates the development of endotoxin responsiveness during differentiation of mononuclear phagocytes , 1994, Journal of leukocyte biology.

[29]  D. Boumpas,et al.  Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.

[30]  M. Kuzuya,et al.  Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  M. Kuzuya,et al.  Effects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. , 1992, Journal of nutritional science and vitaminology.

[32]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[33]  R. Murray,et al.  The effect of high‐dose steroids on MRI gadolinium enhancement in acute demyelinating lesions , 1991, Neurology.

[34]  D. Nashel.  Is atherosclerosis a complication of long-term corticosteroid treatment? , 1986, The American journal of medicine.

[35]  Koanhoi Kim,et al.  Hydroxycholesterol upregulates CD 14 and predisposes monocytic cells to superproduction of CCL 2 in response to lipopolysaccharide , 2015 .

[36]  John Andersson,et al.  Adaptive immunity and atherosclerosis. , 2010, Clinical immunology.

[37]  S. Monier,et al.  Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. , 1998, FEBS letters.